Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 488

Results For "NAL"

5522 News Found

WHO issues emergency use listing for Covaxin
News | November 03, 2021

WHO issues emergency use listing for Covaxin

This is the eighth Covid-19 vaccine to receive Emergency Use Listing


Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia
Biotech | November 02, 2021

Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia

The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice


Built-for-purpose offering for biomolecule attribute monitoring
Medical Device | November 02, 2021

Built-for-purpose offering for biomolecule attribute monitoring

The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation


Thermo Fisher Scientific realigns product portfolio
Medical Device | November 02, 2021

Thermo Fisher Scientific realigns product portfolio

Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific


GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Glamyo Health widens its dental treatment portfolio
Startup | November 01, 2021

Glamyo Health widens its dental treatment portfolio

Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth


EMA encourages companies to submit type I variations by end- November
Policy | November 01, 2021

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021


Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years


Finvasia acquires Gini Health as it moves into healthcare tech
Digitisation | October 29, 2021

Finvasia acquires Gini Health as it moves into healthcare tech

Gini Health works in the domain of personalised healthcare